Cardiovascular risk factors and collateral artery formation

European Journal of Clinical Investigation

Volumn 39, Issue 12, 2009, Pages 1036-1047

  De Groot, D ^a   Pasterkamp, G ^a   Hoefer, I E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Collateral artery growth; Hypertension; Risk factors

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETANERCEPT; FIBROBLAST GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

AGING; ANEMIA; ANGIOGENESIS; ARTERY OCCLUSION; ATHEROSCLEROSIS; BLOOD VESSEL; BLOOD VISCOSITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; EMBRYO DEVELOPMENT; EXPERIMENTAL MODEL; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SMOKING; TREATMENT DURATION;

AGE FACTORS; ANTIHYPERTENSIVE AGENTS; ARTERIES; CARDIOVASCULAR DISEASES; COLLATERAL CIRCULATION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; NEOVASCULARIZATION, PHYSIOLOGIC; OBESITY; RISK FACTORS; SMOKING;

EID: 70449496067     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02205.x     Document Type: Review

References (129)

1. Perez-Castellano N, Garcia EJ, Abeytua M, Soriano J, Serrano JA, Elizaga J et al. Influence of collateral circulation on in-hospital death from anterior acute myocardial infarction. J Am Coll Cardiol 1998 31 : 512 518.
2. Regieli JJ, Jukema JW, Nathoe HM, Zwinderman AH, Ng S, Grobbee DE et al. Coronary collaterals improve prognosis in patients with ischemic heart disease. Int J Cardiol 2009 20 : 257 262.
3. Schaper W, Scholz D. Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol 2003 23 : 1143 1151.
4. Hoefer IE, van RN, Rectenwald JE, Bray EJ, Abouhamze Z, Moldawer LL et al. Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis. Circulation 2002 105 : 1639 1641.
5. Grundmann S, Hoefer I, Ulusans S, Bode C, Oesterle S, Tijssen JG et al. Granulocyte-macrophage colony-stimulating factor stimulates arteriogenesis in a pig model of peripheral artery disease using clinically applicable infusion pumps. J Vasc Surg 2006 43 : 1263 1269.
6. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997 80 : 829 837.
7. Bergmann CE, Hoefer IE, Meder B, Roth H, van RN, Breit SM et al. Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J Leukoc Biol 2006 80 : 59 65.
8. Sabri MN, DiSciascio G, Cowley MJ, Alpert D, Vetrovec GW. Coronary collateral recruitment: functional significance and relation to rate of vessel closure. Am Heart J 1991 121 : 876 880.
9. Sheridan KM, Ferguson MJ, Distasi MR, Witzmann FA, Dalsing MC, Miller SJ et al. Impact of genetic background and aging on mesenteric collateral growth capacity in Fischer 344, Brown Norway, and Fischer 344 x Brown Norway hybrid rats. Am J Physiol Heart Circ Physiol 2007 293 : H3498 505.
10. Helisch A, Wagner S, Khan N, Drinane M, Wolfram S, Heil M et al. Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler Thromb Vasc Biol 2006 26 : 520 526.
11. Chalothorn D, Clayton JA, Zhang H, Pomp D, Faber JE. Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. Physiol Genomics 2007 30 : 179 191.
12. Zbinden S, Clavijo LC, Kantor B, Morsli H, Cortes GA, Andrews JA et al. Interanimal variability in preexisting collaterals is a major factor determining outcome in experimental angiogenesis trials. Am J Physiol Heart Circ Physiol 2007 292 : H1891 7.
13. van W V, Toes RE, Seghers L, Deckers MM, de Vries MR, Eilers PH et al. Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler Thromb Vasc Biol 2007 27 : 2310 2318.
14. Sherman JA, Hall A, Malenka DJ, De Muinck ED, Simons M. Humoral and cellular factors responsible for coronary collateral formation. Am J Cardiol 2006 98 : 1194 1197.
15. Schirmer SH, Fledderus JO, Bot PT, Moerland PD, Hoefer IE, Baan J, Jr. et al. Interferon-(beta) signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice. Circ Res 2008 102 : 1286 1294.
16. Chittenden TW, Sherman JA, Xiong F, Hall AE, Lanahan AA, Taylor JM et al. Transcriptional profiling in coronary artery disease: indications for novel markers of coronary collateralization. Circulation 2006 114 : 1811 1820.
17. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999 100 : 547 552.
18. Rehman J. An inconvenient truth: recognizing individual differences in arteriogenesis. Circ Res 2008 102 : 1146 1147.
19. Aronson DC, Ruys T, van Bockel JH, Briet E, Brommer EJ, Gevers Leuven JA et al. A prospective survey of risk factors in young adults with arterial occlusive disease. Eur J Vasc Surg 1989 3 : 227 232.
20. Menotti A, Lanti M, Kromhout D, Kafatos A, Nedeljkovic S, Nissinen A. Short and long term association of a single serum cholesterol measurement in middle-aged men in prediction of fatal coronary and other cardiovascular events: a cross-cultural comparison through Europe. Eur J Epidemiol 2005 20 : 597 604.
21. Couffinhal T, Silver M, Kearney M, Sullivan A, Witzenbichler B, Magner M et al. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. Circulation 1999 99 : 3188 3198.
22. Duan J, Murohara T, Ikeda H, Katoh A, Shintani S, Sasaki K et al. Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism. Circulation 2000 102 : III370 6.
23. Tirziu D, Moodie KL, Zhuang ZW, Singer K, Helisch A, Dunn JF et al. Delayed arteriogenesis in hypercholesterolemic mice. Circulation 2005 112 : 2501 2509.
24. Czepluch FS, Bergler A, Waltenberger J. Hypercholesterolaemia impairs monocyte function in CAD patients. J Intern Med 2007 261 : 201 204.
25. Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation 2000 101 : 207 213.
26. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995 333 : 1301 1307.
27. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996 335 : 1001 1009.
28. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 2001 21 : 1712 1719.
29. Arslan F, Pasterkamp G, de Kleijn DP. Unraveling pleiotropic effects of statins: bit by bit, a slow case with perspective. Circ Res 2008 103 : 334 336.
30. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000 6 : 1004 1010.
31. Sata M, Nishimatsu H, Suzuki E, Sugiura S, Yoshizumi M, Ouchi Y et al. Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia. FASEB J 2001 15 : 2530 2532.
32. Dincer I, Ongun A, Turhan S, Ozdol C, Ertas F, Erol C. Effect of statin treatment on coronary collateral development in patients with diabetes mellitus. Am J Cardiol 2006 97 : 772 774. (Pubitemid 43313244)
33. Nishikawa H, Miura S, Zhang B, Shimomura H, Arai H, Tsuchiya Y et al. Pravastatin promotes coronary collateral circulation in patients with coronary artery disease. Coron Artery Dis 2002 13 : 377 381.
34. Ovbiagele B, Saver JL, Starkman S, Kim D, Ali LK, Jahan R et al. Statin enhancement of collateralization in acute stroke. Neurology 2007 68 : 2129 2131.
35. Dincer I, Ongun A, Turhan S, Ozdol C, Kumbasar D, Erol C. Association between the dosage and duration of statin treatment with coronary collateral development. Coron Artery Dis 2006 17 : 561 565. (Pubitemid 44231685)
36. Kubo M, Egashira K, Inoue T, Koga J, Oda S, Chen L et al. Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium. Arterioscler Thromb Vasc Biol 2009 29 : 796 801.
37. Izumi Y, Shiota M, Kusakabe H, Hikita Y, Nakao T, Nakamura Y et al. Pravastatin accelerates ischemia-induced angiogenesis through AMP-activated protein kinase. Hypertens Res 2009 32 : 675 679.
38. Sata M, Nishimatsu H, Osuga J, Tanaka K, Ishizaka N, Ishibashi S et al. Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis. Hypertension 2004 43 : 1214 1220.
39. Chatzizisis YS, Giannoglou GD. Coronary hemodynamics and atherosclerotic wall stiffness: a vicious cycle. Med Hypotheses 2007 69 : 349 355.
40. Cai WJ, Kocsis E, Luo X, Schaper W, Schaper J. Expression of endothelial nitric oxide synthase in the vascular wall during arteriogenesis. Mol Cell Biochem 2004 264 : 193 200.
41. Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, Chilian WM. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 2000 102 : 3098 3103.
42. Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, Tedgui A. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler Thromb Vasc Biol 2000 20 : E120 6.
43. Tuttle JL, Nachreiner RD, Bhuller AS, Condict KW, Connors BA, Herring BP et al. Shear level influences resistance artery remodeling: wall dimensions, cell density, and eNOS expression. Am J Physiol Heart Circ Physiol 2001 281 : H1380 9.
44. Yu J, deMuinck ED, Zhuang Z, Drinane M, Kauser K, Rubanyi GM et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci U S A 2005 102 : 10999 10004.
45. Benndorf R, Boger RH, Ergun S, Steenpass A, Wieland T. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ Res 2003 93 : 438 447.
46. Kou B, Vatish M, Singer DR. Effects of angiotensin II on human endothelial cells survival signalling pathways and its angiogenic response. Vascul Pharmacol 2007 47 : 199 208.
47. Le Noble FA, Hekking JW, Van Straaten HW, Slaaf DW, Struyker Boudier HA. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 1991 195 : 305 306.
48. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000 87 : 840 844.
49. Rocic P, Kolz C, Reed R, Potter B, Chilian WM. Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth. Am J Physiol Heart Circ Physiol 2007 292 : H2729 36.
50. Chua CC, Hamdy RC, Chua BH. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1998 1401 : 187 194.
51. Otani A, Takagi H, Suzuma K, Honda Y. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 1998 82 : 619 628. (Pubitemid 28129033)
52. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989 83 : 1419 1424.
53. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993 91 : 2268 2274.
54. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 1992 16 : 181 191.
55. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003 9 : 604 613.
56. Rajanayagam MA, Shou M, Thirumurti V, Lazarous DF, Quyyumi AA, Goncalves L et al. Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs. J Am Coll Cardiol 2000 35 : 519 526.
57. Yang HT, Deschenes MR, Ogilvie RW, Terjung RL. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ Res 1996 79 : 62 9.
58. Koerselman J, de Jaegere PP, Verhaar MC, van der GY, Grobbee DE. High blood pressure is inversely related with the presence and extent of coronary collaterals. J Hum Hypertens 2005 19 : 809 817.
59. Kyriakides ZS, Kremastinos DT, Michelakakis NA, Matsakas EP, Demovelis T, Toutouzas PK. Coronary collateral circulation in coronary artery disease and systemic hypertension. Am J Cardiol 1991 67 : 687 690.
60. Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996 94 : 258 265.
61. Emanueli C, Salis MB, Stacca T, Pinna A, Gaspa L, Spano A et al. Ramipril improves hemodynamic recovery but not microvascular response to ischemia in spontaneously hypertensive rats. Am J Hypertens 2002 15 : 410 415.
62. Miura S, Nishikawa H, Zhang B, Matsuo Y, Kawamura A, Tsuchiya Y et al. Angiotensin-converting enzyme inhibitor promotes coronary collateral circulation in patients with coronary artery disease. Circ J 2003 67 : 535 538.
63. Fabre JE, Rivard A, Magner M, Silver M, Isner JM. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation 1999 99 : 3043 3049.
64. Imaizumi S, Miura S, Nishikawa H, Iwata A, Zhang B, Kawamura A et al. Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease. Hypertens Res 2006 29 : 135 141.
65. Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2006 187 : 423 432.
66. Nagai K, Betsuyaku T, Ito Y, Nasuhara Y, Nishimura M. Decrease of vascular endothelial growth factor in macrophages from long-term smokers. Eur Respir J 2005 25 : 626 633. (Pubitemid 40528754)
67. Michaud SE, Dussault S, Groleau J, Haddad P, Rivard A. Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species. J Mol Cell Cardiol 2006 41 : 275 284.
68. Stadler N, Eggermann J, Voo S, Kranz A, Waltenberger J. Smoking-induced monocyte dysfunction is reversed by vitamin C supplementation in vivo. Arterioscler Thromb Vasc Biol 2007 27 : 120 126.
69. Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001 7 : 833 839.
70. Heeschen C, Weis M, Aicher A, Dimmeler S, Cooke JP. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 2002 110 : 527 536.
71. Heeschen C, Weis M, Cooke JP. Nicotine promotes arteriogenesis. J Am Coll Cardiol 2003 41 : 489 496.
72. Davies BD, Hoss W, Lin JP, Lionetti F. Evidence for a noncholinergic nicotine receptor on human phagocytic leukocytes. Mol Cell Biochem 1982 44 : 23 31. (Pubitemid 12087076)
73. Ng MK, Wu J, Chang E, Wang BY, Katzenberg-Clark R, Ishii-Watabe A et al. A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration. Arterioscler Thromb Vasc Biol 2007 27 : 106 112.
74. Gray C, Packham IM, Wurmser F, Eastley NC, Hellewell PG, Ingham PW et al. Ischemia is not required for arteriogenesis in zebrafish embryos. Arterioscler Thromb Vasc Biol 2007 27 : 2135 2141.
75. Michaud SE, Menard C, Guy LG, Gennaro G, Rivard A. Inhibition of hypoxia-induced angiogenesis by cigarette smoke exposure: impairment of the HIF-1alpha/VEGF pathway. FASEB J 2003 17 : 1150 1152.
76. Cohen M, Sherman W, Rentrop KP, Gorlin R. Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects. J Am Coll Cardiol 1989 13 : 297 303.
77. Fujita M, Nakae I, Kihara Y, Hasegawa K, Nohara R, Ueda K et al. Determinants of collateral development in patients with acute myocardial infarction. Clin Cardiol 1999 22 : 595 599. (Pubitemid 29416188)
78. Kilian JG, Keech A, Adams MR, Celermajer DS. Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coron Artery Dis 2002 13 : 155 159.
79. Kornowski R. Collateral formation and clinical variables in obstructive coronary artery disease: the influence of hypercholesterolemia and diabetes mellitus. Coron Artery Dis 2003 14 : 61 4.
80. Koerselman J, de Jaegere PP, Verhaar MC, Grobbee DE, van der GY. Coronary collateral circulation: the effects of smoking and alcohol. Atherosclerosis 2007 191 : 191 198.
81. Haffner SM. Coronary heart disease in patients with diabetes. N Engl J Med 2000 342 : 1040 1042.
82. Weihrauch D, Lohr NL, Mraovic B, Ludwig LM, Chilian WM, Pagel PS et al. Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin. Circulation 2004 109 : 2343 2348.
83. Schofield I, Malik R, Izzard A, Austin C, Heagerty A. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002 106 : 3037 3043.
84. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999 99 : 2239 2242.
85. Melidonis A, Tournis S, Kouvaras G, Baltaretsou E, Hadanis S, Hajissavas I et al. Comparison of coronary collateral circulation in diabetic and nondiabetic patients suffering from coronary artery disease. Clin Cardiol 1999 22 : 465 471.
86. Zbinden R, Zbinden S, Billinger M, Windecker S, Meier B, Seiler C. Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy. Heart 2005 91 : 1289 1293.
87. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 2001 49 : 554 560.
88. Sodha NR, Boodhwani M, Clements RT, Xu SH, Khabbaz KR, Sellke FW. Increased antiangiogenic protein expression in the skeletal muscle of diabetic swine and patients. Arch Surg 2008 143 : 463 470.
89. Mouquet F, Cuilleret F, Susen S, Sautiere K, Marboeuf P, Ennezat PV et al. Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1. Eur Heart J 2009 30 : 840 849.
90. Piek JJ, Koolen JJ, Metting van Rijn AC, Bot H, Hoedemaker G, David GK et al. Spectral analysis of flow velocity in the contralateral artery during coronary angioplasty: a new method for assessing collateral flow. J Am Coll Cardiol 1993 21 : 1574 1582.
91. Sabia PJ, Powers ER, Jayaweera AR, Ragosta M, Kaul S. Functional significance of collateral blood flow in patients with recent acute myocardial infarction. A study using myocardial contrast echocardiography. Circulation 1992 85 : 2080 2089.
92. Rand LI. Recent advances in diabetic retinopathy. Am J Med 1981 70 : 595 602.
93. Schaper W, Buschmann I. Collateral circulation and diabetes. Circulation 1999 99 : 2224 2226.
94. van Weel V, de Vries M, Voshol PJ, Verloop RE, Eilers PH, van Hinsbergh V et al. Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice. Arterioscler Thromb Vasc Biol 2006 26 : 1383 1390.
95. Stathakis P, Fitzgerald M, Matthias LJ, Chesterman CN, Hogg PJ. Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells. J Biol Chem 1997 272 : 20641 20645.
96. Moser TL, Stack MS, Asplin I, Enghild JJ, Hojrup P, Everitt L et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci U S A 1999 96 : 2811 2816.
97. Moser TL, Kenan DJ, Ashley TA, Roy JA, Goodman MD, Misra UK et al. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA 2001 98 : 6656 6661.
98. Claesson-Welsh L, Welsh M, Ito N, nand-Apte B, Soker S, Zetter B et al. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci U S A 1998 95 : 5579 5583.
99. Lucas R, Holmgren L, Garcia I, Jimenez B, Mandriota SJ, Borlat F et al. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 1998 92 : 4730 4741.
100. van Golde JM, Ruiter MS, Schaper NC, Voo S, Waltenberger J, Backes WH et al. Impaired collateral recruitment and outward remodeling in experimental diabetes. Diabetes 2008 57 : 2818 2823.
101. Zhou B, Bi YY, Han ZB, Ren H, Fang ZH, Yu XF et al. G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability. J Thromb Haemost 2006 4 : 993 1002.
102. I'allemand D, Wiegand S, Reinehr T, Muller J, Wabitsch M, Widhalm K et al. Cardiovascular risk in 26,008 European Overweight Children as Established by a Multicenter Database. Obesity (Silver Spring) 2008 16 : 1672 1679.
103. Cannon CP. Cardiovascular disease and modifiable cardiometabolic risk factors. Clin Cornerstone 2007 8 : 11 28.
104. Sasmaz H, Yilmaz MB. Coronary Collaterals in Obese Patients: Impact of Metabolic Syndrome. Angiology 2008 60 : 164 168.
105. Yilmaz MB, Biyikoglu SF, Akin Y, Guray U, Kisacik HL, Korkmaz S. Obesity is associated with impaired coronary collateral vessel development. Int J Obes Relat Metab Disord 2003 27 : 1541 1545.
106. Yilmaz MB, Caldir V, Guray Y, Guray U, Altay H, Demirkan B et al. Relation of coronary collateral vessel development in patients with a totally occluded right coronary artery to the metabolic syndrome. Am J Cardiol 2006 97 : 636 639.
107. Turhan H, Yasar AS, Erbay AR, Yetkin E, Sasmaz H, Sabah I. Impaired coronary collateral vessel development in patients with metabolic syndrome. Coron Artery Dis 2005 16 : 281 285. (Pubitemid 41073296)
108. Harris R, Piracha AR. Acute myocardial infarction in the aged: prognosis and management. J Am Geriatr Soc 1970 18 : 893 904.
109. Latting CA, Silverman ME. Acute myocardial infarction in hospitalized patients over age 70. Am Heart J 1980 100 : 311 318.
110. Yang XS, Willems JL, Pardaens J, De GH. Acute myocardial infarction in the very elderly. A comparison with younger age groups. Acta Cardiol 1987 42 : 59 68.
111. Disterhoft JF, Oh MM. Alterations in intrinsic neuronal excitability during normal aging. Aging Cell 2007 6 : 327 336.
112. Ashcroft GS, Herrick SE, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA. J Pathol 1997 183 : 169 176.
113. Allsopp RC, Harley CB. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 1995 219 : 130 136.
114. Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M et al. Age-dependent impairment of angiogenesis. Circulation 1999 99 : 111 120.
115. Bruunsgaard H, ndersen-Ranberg K, Hjelmborg JB, Pedersen BK, Jeune B. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med 2003 115 : 278 283.
116. Makinodan T. Role of the immune system in aging. Adv Exp Med Biol 1980 129 : 213 231.
117. Nakae I, Fujita M, Miwa K, Hasegawa K, Kihara Y, Nohara R et al. Age-dependent impairment of coronary collateral development in humans. Heart Vessels 2000 15 : 176 180. (Pubitemid 32573966)
118. Tuttle JL, Hahn TL, Sanders BM, Witzmann FA, Miller SJ, Dalsing MC et al. Impaired collateral development in mature rats. Am J Physiol Heart Circ Physiol 2002 283 : H146 55.
119. Kurotobi T, Sato H, Kinjo K, Nakatani D, Mizuno H, Shimizu M et al. Reduced collateral circulation to the infarct-related artery in elderly patients with acute myocardial infarction. J Am Coll Cardiol 2004 44 : 28 34.
120. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation 1991 83 : 739 746.
121. Abete P, Ferrara N, Cioppa A, Ferrara P, Bianco S, Calabrese C et al. Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol 1996 27 : 1777 1786.
122. Abete P, Ferrara N, Cacciatore F, Madrid A, Bianco S, Calabrese C et al. Angina-induced protection against myocardial infarction in adult and elderly patients: a loss of preconditioning mechanism in the aging heart? J Am Coll Cardiol 1997 30 : 947 954.
123. Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 2008 121 : S3 8.
124. Curtis JR, Kramer JM, Martin C, Saag KG, Patkar N, Shatin D et al. Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists. Rheumatology (Oxford) 2007 46 : 1688 1693.
125. Grundmann S, Hoefer I, Ulusans S, van RN, Schirmer SH, Ozaki CK et al. Anti-tumor necrosis factor-(alpha) therapies attenuate adaptive arteriogenesis in the rabbit. Am J Physiol Heart Circ Physiol 2005 289 : H1497 505.
126. Scholz D, Schaper W. Enhanced arteriogenesis in mice overexpressing erythropoietin. Cell Tissue Res 2006 324 : 395 401.
127. Girolami B, Bernardi E, Prins MH, Ten Cate JW, Hettiarachchi R, Prandoni P et al. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med 1999 159 : 337 345.
128. Kaufmann PA, Mandinov L, Seiler C, Hess OM. Impact of exercise-induced coronary vasomotion on anti-ischemic therapy. Coron Artery Dis 2000 11 : 363 369.
129. Prior BM, Yang HT, Terjung RL. What makes vessels grow with exercise training? J Appl Physiol 2004 97 : 1119 1128.